Structure Therapeutics Inc ADR (NASDAQ:GPCR) price on Thursday, July 03, fall -0.37% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $20.36.
A look at the stock’s price movement, the close in the last trading session was $20.44, moving within a range at $19.83 and $20.81. The beta value (5-Year monthly) was -1.971. Turning to its 52-week performance, $47.48 and $13.22 were the 52-week high and 52-week low respectively. Overall, GPCR moved -7.31% over the past month.
Structure Therapeutics Inc ADR’s market cap currently stands at around $1.17 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GPCR is a 100% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend GPCR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GPCR’s current price about -4.60% and -12.33% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.49, while 7-day volatility ratio is 4.42% and 6.14% in the 30-day chart. Further, Structure Therapeutics Inc ADR (GPCR) has a beta value of -1.95. Analysts have given the company’s stock an average 52-week price target of $93, forecast between a low of $65 and high of $118. Looking at the price targets, the low is -219.25% off current price level while to achieve the yearly target high, price needs to move -479.57%. Nonetheless, investors will most likely welcome a -356.78% jump to $93 which is the analysts’ median price.
If we refocus on Structure Therapeutics Inc ADR (NASDAQ:GPCR), historical trading data shows that trading volumes averaged 0.68 over the past 10 days and 931.01K over the past 3 months. The company’s latest data on shares outstanding shows there are 57.54 million shares.
The 4.94% of Structure Therapeutics Inc ADR’s shares are in the hands of company insiders while institutional holders own 93.70% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.27 million on 2025-06-13, giving us a short ratio of 9.89. The data shows that as of 2025-06-13 short interest in Structure Therapeutics Inc ADR (GPCR) stood at 2076.0 of shares outstanding, with shares short falling to 9.32 million registered in 2025-05-15. Current price change has pushed the stock -49.09% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GPCR stock continues to rise going into the next quarter.
